Loading...
Potential COVID-19 papain-like protease PL(pro) inhibitors: repurposing FDA-approved drugs
Using the crystal structure of SARS-CoV-2 papain-like protease (PL(pro)) as a template, we developed a pharmacophore model of functional centers of the PL(pro) inhibitor-binding pocket. With this model, we conducted data mining of the conformational database of FDA-approved drugs. This search identi...
Saved in:
| Published in: | PeerJ |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
PeerJ Inc.
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7505060/ https://ncbi.nlm.nih.gov/pubmed/32999768 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7717/peerj.9965 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|